CBLL
NASD Ceribell, Inc.$26.06 ↓ -1.58 (-5.72%) Trading Down from the previous close of $27.64, $1.42 below the day’s high of $27.48
- YTD change
- +18.83%
- vs 20-day SMA
- +6.38%
- vs 200-day SMA
- +26.96%
Price ranges
Price & Performance
+6.90 (+33.27%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 20.4% away from all-time highs of $32.75
- CBLL is up 19% since the beginning of the year
- CBLL is up 101% over the past 12 months
- CBLL is up 4% over the past 1 month
- 8% of all CBLL investors are betting against CBLL
CBLL reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +112.8%.
- Previous minute
- -$0.09
- Last hour
- -$0.60
- Last 5 days
- +12.57%
- vs 8-day SMA
- +4.23%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
